title: [Adjuvant therapy in breast carcinoma. A specific immunologic preliminary contribution].
authors.forename: M
authors.initials: M
authors.lastname: Fazio
authors.forename: F
authors.initials: F
authors.lastname: Calabrese
authors.forename: S
authors.initials: S
authors.lastname: Giacomasso
authors.forename: V
authors.initials: V
authors.lastname: Mastromatteo
authors.forename: L
authors.initials: L
authors.lastname: Negri
mesh_terms: D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D011379:Prognosis; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D013629:Tamoxifen
vernacular_title: La terapia adiuvante nel carcinoma mammario. Preliminare contributo immunologico specifico.